Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

Nvidia’s Surge Drives Nasdaq to All-Time High Amid New Tariff Threats

by Team Lumida
2 days ago
Nvidia’s Stock: Is It Too Good to Be True Now?

Key Takeaways: Powered by lumidawealth.com Market Rally: The Nasdaq composite reached a new all-time high, and the S&P 500 and Dow Jones Industrial Average also posted gains, despite fresh...

Read more

Starbucks Considers Selling Stake in China Unit Amid Investor Interest

by Team Lumida
3 days ago
two white starbucks disposable cups

Key Takeaways: Powered by lumidawealth.com Investor Proposals: Starbucks has received non-binding proposals from potential investors, with most seeking a controlling stake in its China business. Preferred Strategy: While Starbucks...

Read more

Apple COO Jeff Williams to Step Down, Sabih Khan to Succeed Him

by Team Lumida
3 days ago
Apple COO Jeff Williams to Step Down, Sabih Khan to Succeed Him

Key Takeaways: Powered by lumidawealth.com Leadership Transition: Apple’s Chief Operating Officer Jeff Williams will step down this month and retire later this year after a 25-year tenure at the...

Read more

UniCredit Doubles Stake in Commerzbank to 20%, Becoming Largest Shareholder

by Team Lumida
3 days ago
UniCredit Doubles Stake in Commerzbank to 20%, Becoming Largest Shareholder

Key Takeaways: Powered by lumidawealth.com Stake Increase: UniCredit has converted derivatives into stock, doubling its equity stake in Commerzbank to 20%, surpassing the German government as the largest shareholder....

Read more

Amazon Extends Prime Day to Four Days, Aiming for Record $12.9 Billion in U.S. Sales

by Team Lumida
5 days ago
Amazon Targets Rural America: A Game-Changer for Delivery Services

Key Takeaways: Powered by lumidawealth.com Extended Event: Amazon has doubled the length of Prime Day to four days, aiming to boost sales and attract new Prime members. Record Sales...

Read more

Chinese Bubble Tea Stocks Surge Amid Food-Delivery Platforms’ Discount War

by Team Lumida
5 days ago
Chinese Bubble Tea Stocks Surge Amid Food-Delivery Platforms’ Discount War

Key Takeaways: Powered by lumidawealth.com Stock Gains: Shares of Chinese bubble tea brands, including Sichuan Baicha Baidao Industrial (+7.3%), Guming Holdings (+7.5%), and Mixue Group (+3.0%), rose as food-delivery...

Read more

Shell’s Upstream Production to Decline in Q2 Amid Maintenance and Asset Sale in Nigeria

by Team Lumida
5 days ago
low angle photography of Shell gas station at night

Key Takeaways: Powered by lumidawealth.com Production Decline: Shell expects Q2 upstream production to fall to 1.66–1.76 million barrels of oil equivalent per day (boe/d), down from 1.855 million boe/d...

Read more

Tesla Faces Sales Slump Amid Competition, Political Backlash, and Delayed Innovation

by Team Lumida
1 week ago
blue coupe parked beside white wall

Key Takeaways: Powered by lumidawealth.com Declining Sales: Tesla’s vehicle deliveries are on track to decline for the second consecutive year, with Q2 sales down 13% year-over-year and U.S. market...

Read more

Goldman Sachs Lowers Treasury Yield Forecasts Amid Rising Fed Rate Cut Expectations

by Team Lumida
1 week ago
Goldman Sachs Urges Investors to Cut Risk: Is a Selloff Looming?

Key Takeaways: Powered by lumidawealth.com Revised Yield Forecasts: Goldman Sachs now expects 2-year Treasury yields to end 2025 at 3.45% and 10-year yields at 4.20%, down from previous forecasts...

Read more

China’s Share of US Imports Drops to 7% as Vietnam and Taiwan Gain Ground

by Team Lumida
1 week ago
Chinese Stock Surge: A Hedge Fund Headache?

Key Takeaways: Powered by lumidawealth.com China’s Declining Share: China’s share of US imports fell to 7.1% in May 2025, the lowest since 2001, down from 14.8% in September 2024....

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

red and blue light streaks

Hedge Funds Bet Big on Yen: What You Need to Know

August 17, 2024
Why Tokens Are Sabotaging AI: The Hidden Flaw in Generative Models

Why Tokens Are Sabotaging AI: The Hidden Flaw in Generative Models

July 7, 2024
Blackrock Q2 2024 Earnings Summary

BlackRock’s Bitcoin ETF Faces 11% Drop Amid $1 Billion Outflows and Record Trading Volumes

March 5, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018